Compare CNTB & GGZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNTB | GGZ |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.6M | 129.8M |
| IPO Year | 2020 | 2013 |
| Metric | CNTB | GGZ |
|---|---|---|
| Price | $2.80 | $15.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.67 | N/A |
| AVG Volume (30 Days) | ★ 252.3K | 9.9K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $64,000.00 | N/A |
| Revenue This Year | $84,907.81 | N/A |
| Revenue Next Year | $92.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $10.50 |
| 52 Week High | $3.82 | $16.80 |
| Indicator | CNTB | GGZ |
|---|---|---|
| Relative Strength Index (RSI) | 48.77 | 41.29 |
| Support Level | $2.16 | $14.65 |
| Resistance Level | $2.94 | $15.44 |
| Average True Range (ATR) | 0.33 | 0.25 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 18.90 | 30.00 |
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
The Gabelli Global Small and Mid Cap Value Trust is a diversified closed-ended management investment company whose investment objective is long-term capital growth. It invests in equity securities such as common stock and preferred stock of companies.